SCHEMBL6350945

SCHEMBL6350945

CC(=O)Cc1nc2ccc(Cl)cc2c(=O)o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1R P00736 2/20 0.46
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 2/20 0.46
ELANE P08246 7/20 0.45
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
MAOB P27338 1/20 0.40
AKR1B1 P15121 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6349049 0.84 ELANE (0.59) C1RKDM4EALDH1A1ELANELMNA
SCHEMBL6341584 0.82 ELANE (0.44) KDM4EELANE
SCHEMBL6565207 0.82 C1R (0.52) C1RKDM4EALDH1A1ELANEAPEX1
SCHEMBL5370167 0.80 ELANE (0.68) C1RELANE
SCHEMBL6353490 0.80 ELANE (0.51) C1RKDM4EALDH1A1ELANELMNA
SCHEMBL11710939 0.76 KDM4E (0.54) C1RKDM4EALDH1A1ELANELMNA
SCHEMBL6344210 0.75 KDM4E (0.60) C1RKDM4EALDH1A1ELANELMNA
SCHEMBL6567394 0.75 ELANE (0.49) C1RKDM4EALDH1A1ELANELMNA
SCHEMBL1812732 0.74 ELANE (0.70) C1RKDM4EALDH1A1ELANELMNA
SCHEMBL31000399 0.74 ELANE (0.70) C1RKDM4EALDH1A1ELANELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 C1R 380/4885KDM4E 1741/4885ALDH1A1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.